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The aims of this study were (1) to investigate what are the illness perceptions
of hypertensive patients and their relationship with beliefs about specific
medicines, and (2) to identify different illness schemata and how they relate
to the choice of medication. This was a cross-sectional study in which 191
Portuguese patients (59% females), with a hypertension diagnosis, aged over
18 years old, were recruited from a hospital clinic in the Lisbon Metropolitan
area. The questionnaire included measures of choice of medication, beliefs
about specific medicines (BMQ-Specific), illness perception (Brief-IPQ), and
socio-demographic information. The results indicated that the components of the
illness perceptions were associated with patients’ beliefs about necessity and
concerns about medication. Patients seem to differ in their choice of medication
(generic or brand names) according to the three illness schemata identified.
Patients with more negative illness schemata were more likely to choose a brand
medicine, whereas patients with a more positive perception of hypertension were
more likely to choose a generic medicine. Our findings support the argument that
illness perceptions and beliefs about medicines play a role in influencing patients’
preferences of medicines for the treatment of hypertension.
Keywords: illness perceptions; hypertension; choice of medication; beliefs about
generic medicines
Introduction
Hypertension is a major public health problem and is one of the major causes
of worldwide morbidity and mortality. According to the World Health Organization
(WHO Publications – Cardiovascular Diseases, 2001, 2002), currently hypertension affects
about 600 million people worldwide. In Portugal, a recent study with 5023 adults indicated
a prevalence of hypertension of about 42% (Macedo et al., 2005), and the guidelines for
treatment and management are based on the European Society of Hypertension (ESH)
and the European Society of Cardiology (ESH & ESC, 2007).
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Hypertension has been identified as one of the most prevalent risk factors for
the development of coronary artery disease, stroke, peripheral vascular disease, renal
failure, and congestive heart failure (Nasilowska-Barud & Kowalik, 2004; Volpe
& Dedhiya, 2006). Despite improvements in its detection and treatment since the 1970s,
several studies have shown that 60–75% of treated hypertensive patients do not reach the
recommended target blood pressure of 150/90mmHg (Inkster, Donnan, MacDonald,
Sullivan, & Fahey, 2006). Hypertension is a chronic illness with serious economic and
clinical consequences, and the asymptomatic nature of this condition contributes to the
challenge of persistent medication use (Polo´nia, Ramalhinho, Martins, & Saavedra 2006;
Viswanathan & Lambert, 2005). It has been estimated that approximately 50% of the
hypertensive population does not take the prescribed medication (Dubiel, Cwynar,
Januszewicz, & Grodzicki, 2005). Several factors such as lack of association of symptoms
to hypertension, the complexity of the therapy prescribed, possible side-effects, or
economical factors may contribute for non-compliance. These factors may be better
conceptualised as patients’ illness perceptions. Some studies have investigated the
perception that hypertensive patients have about their illness and treatment
(Heijmans & Ridder, 1998; Horne, Clatworthy, Polmear, & Weinman, 2001). A number
of studies (e.g. Petrie & Weinman, 2006) have shown that when patients are diagnosed
with an illness they generally develop an organised pattern of beliefs about their condition.
Meyer, Leventhal, and Gutmann (1985) proposed the common-sense model of illness
representations to understand the processes by which people make sense of illness. The
representation is viewed as a schema that is formed, activated, and modified in response to
a range of influences, such as the nature of the symptoms, prior knowledge, and
information from experts (e.g. general practitioners) and lay people (Petrie, Jago, &
Devich, 2007). It has been shown that when patients hold generally negative illness
perceptions about their illness, for instance, a large number of symptoms associated with
the condition, more severe consequences, and longer timeline beliefs, these perceptions
may be important determinants of behaviour and outcomes, such as treatment adherence
and functional recovery (Petrie & Weinman, 2006; Petrie et al., 2007). According to Peres,
Magna, and Viana (2003) patients have a belief system distorted in relation to
hypertension, which is associated with a partial knowledge about various aspects of
hypertension. In spite of hypertension being known as an asymptomatic health problem,
most of the people with such diagnosis are convinced that they experience very specific
symptoms associated to changes in blood pressure (Ross, Walker, & MacLeado, 2004).
The same authors referred that the illness representations of hypertensive patients
indicated strong perceptions of chronicity, although not related to compliance to
medication. Some studies suggested that beliefs about the illness and medication are
influential in patients’ decisions about whether or not to take the prescribed medication
(Horne & Weinman, 1999). The first prospective follow-up study to assess the role
of patients’ beliefs about hypertension and its treatment on subsequent adherence and
quality of life indicated that the patients’ perceptions of their illness did explain
a significant proportion of the variance between clinical disease severity and disability
(Horne et al., 2001). In addition, such beliefs and attitudes about hypertension and
treatment, patients’ knowledge about medicines, and socio-demographic factors, may
affect treatment adherence (Krousel-Wood, Thomas, Muntner, & Morisky, 2004; Petrie
& Weinman, 2006).
Recent studies have shown that hypertensive patients use information about
symptoms to regulate the type of decisions they make in adhering to treatment (Gamez,
Roales-Nieto, & Sagarduy, 2006). Patients’ acceptance of medical advice and information

































may be influenced by their subjective beliefs about their health condition. Therefore, it is
essential that these beliefs should be taken into account when giving health advice or
medical treatment (Patel & Taylor, 2002). Healthcare professionals have both private and
professional beliefs about medicines (Ogden, 2004), and it is likely that a mixture of these
beliefs affects how and what information about medicines is communicated between
themselves and the patient. This may decrease the possibility of achieving concordance in
relation to sharing treatment decisions (Weiss & Britten, 2003) which is an important
factor associated with adherence (Clifford, Barber, Elliot, Hartley, & Horne, 2006).
According to Petrie and Weinman (2006) there is accumulating evidence that the lack of
motivation to comply with the treatment often arises from mistaken beliefs about its
necessity or from concerns about the potential adverse effects. Previous research has also
shown that patients develop beliefs about the necessity of a specific medication for
maintaining their health status (Horne & Weinman, 1999). A recent study suggested that
hypertensive patients perceived medications to be necessary, but a substantial proportion
had concerns about taking medicines (Ross et al., 2004). In general, these findings
indicated that the beliefs about medicines may influence attitudes and beliefs about
treatment for particular illnesses (Horne & Weinman, 1999). These authors also indicated
that little is known about how patients make decisions concerning medicines or about their
preferences for one drug or another. It is likely that the choice of medicines can be
determined by the patients’ perception about their disease, including its severity, benefits,
and barriers to treatment. Thus we can assume that the patients’ models of hypertension
and their beliefs about medicines will all have an important role in decisions about the type
of treatment.
In this sense, the aims of this study were: (1) to investigate what are the illness
perceptions of hypertensive patients and their relationship with beliefs about specific
medicines, and (2) to identify different illness schemata and how they relate to the choice
of medication (generic versus brand).
Method
Design and participants
This study was cross-sectional. The participants were an opportunistic sample of
Portuguese patients with a diagnosis of hypertension of at least 3 years duration.
Patients were all aged 18 years old or over and recruited from a specialist cardiology out-
patient clinic from the National Health Service, in the Lisbon Metropolitan area. Other
inclusion criteria were being able to read, having their rate of blood pressure under control
and keeping their regular appointments over the last year. For confidentiality reasons
it was not possible to have access to personal and clinical data other than age and level
of education.
Procedure
Patients who met the inclusion criteria, they were invited to participate by the clinic nurse
before their appointment with the cardiologist. Each participant was invited to complete
an anonymous questionnaire administered by a research assistant. Participation was
voluntary. The participants who declined to participate did not provide any data, which
meant it was not possible to compare decliners with the study participants.



































Participants were asked what medicines they would choose if they were given a choice.
This was assessed with a dichotomous variable (generic or brand).
Beliefs about specific medicines questionnaire (BMQ-specific) – (Horne, Weinman, &
Hankins, 1999)
The BMQ-specific has two factors: necessity (5 statements – 1;3;4;8;10) and concerns
(5 statements – 2;5;6;7;9) and has been shown to have satisfactory psychometric properties
(in the present study, ¼ 0.81 and 0.74, respectively). Higher scores mean higher
agreement with the necessity of treatment, and higher concerns about taking their
medication. Responses to each statement were scored on a five-point Likert scale
(from 1¼ strongly disagree to 5¼ strongly agree).
Brief illness perception questionnaire (Brief-IPQ, translated version) – (Broadbent,
Petrie, Main, & Weinman, 2006)
The Brief – IPQ has eight items. Five items assess cognitive illness representations:
consequences (Item 1), timeline (Item 2), personal control (Item 3), treatment control
(Item 4), and identity (Item 5); two items assess emotional representations: concern
(Item 6) and emotions (Item 8); and one item assesses illness comprehensibility (Item 7).
All the items are rated using 0–10 response scale. The items 3, 4, and 7 were reversed.
Higher scores mean a more negative illness perception. The causal attributions were not
included in the present study.
Socio-demographic information
Age, gender, and level of education.
For analysis purposes, the level of education was measured according to the national
education plan in Portugal: Basic (1st level – 4 years, 2nd level – 6 years, 3rd level –
9 years), Secondary – 12 years; and University – Licenciatura (BSc), Mestrado (MSc),
Doutoramento (PhD).
Analysis
The data analysis was performed using the SPSS software for Windows (version 15; SPSS
Inc, Chicago, IL). Pearson correlations were used to investigate possible relationships
between illness perceptions and beliefs about medicines. To reduce the probability
of a type II error, post hoc power calculations were performed using Gpower 3.0
(Faul, Erdfelder, Lang, & Buchner, 2007) to detect an medium effect size to a significance
level of p5 0.05, for each used test (Table 1). A cluster analysis was performed in order to
identify groups of patients that share a similar pattern of illness perceptions and whether
these profiles influenced their choice of treatment. Associations between patterns of illness
perceptions or schemata, and choice of treatment were assessed by Pearson 2 tests.
Statistical results were considered statistically significant for p5 0.05. Odds ratio for the
generic vs. brand medicine and its interaction with the illness schemata was assessed by
a Log-linear with ordinal row effects.



































The total sample was composed of 241 Portuguese (50 declined to participate),
giving a response rate of 79%. The final sample was composed of 191 individuals:
112 females (59%), with a mean age of 62 years old (SD¼ 11.4; range¼ 36–84).
Concerning level of education, 50% (N¼ 96) of the participants had completed primary
education, 13% (N¼ 25), 12% (N¼ 23), and 13% (N¼ 25) had completed 6, 9, and
12 years of formal education, respectively, and 12% (N¼ 22) had completed University
degrees.
Correlations between BMQ specific and illness perceptions
In general, patients perceived medication to be necessary [mean¼ 3.91 (0.68)] and
show a moderate level of concern about their medicines [mean¼ 3.36 (0.77)].
Pearson correlations indicated that the components of the illness perceptions were
associated with participants beliefs about necessity and concerns about medication
(Table 2). A greater belief in the necessity and concern about treatment was associated
with a more negative perception of hypertension in terms of consequences, chronic
timeline, more symptoms, greater concern and a more negative emotional representation.
A greater belief in personal and treatment control was positively associated with
the necessity of treatment and it was not associated with concern about taking
medicines (Table 2).
Table 1. Post hoc power calculations with a medium effect
size for p5 0.05 (GPower).
Statistic test N Effect size Power (%)
2 171 w¼ 0.30 99
Pearson correlations 191 r¼ 0.30 99
t-test 191 d¼ 0.50 92
One-way Anova 191 f¼ 0.25 88
Table 2. Correlations between beliefs about medicines




Personal control 0.325** 0.103
Treatment control 0.299** 0.142
Identity 0.377*** 0.428***
Concern 0.293** 0.303**
Illness comprehensibility 0.075 0.055
Emotions 0.323** 0.437***
Note: **p5 0.01; ***p5 0.001.

































Illness schemata of hypertension
The results indicated that the patients’ common-sense model of hypertension is composed
of beliefs about serious consequences, chronic timeline, high concern, and a negative
emotional representation, although showing a strong belief in personal and treatment
control, and good comprehensibility. The means for the illness schemata of hypertension
are depicted in Figure 1.
A Hierarchical Cluster Analysis was performed using Ward’s Method to identify
different illness schemata of hypertension. The choice of the number of clusters was based
on previous health psychology research. A review of 59 of these studies using cluster
analysis found that the median number of clusters identified was four (Clatworthy, Buick,
Hankins, Weinman, & Horne, 2005). In the present study, three clusters were therefore
generated as this number appeared relatively typical of the number of groups found both
in illness perception research and health psychology research in general, as referred by
a recent study (Clatworthy, Hankins, Buick, Weinman, & Horne, 2007). The results
indicated three illness schemata of hypertension (Table 3). Patients in cluster 1 showed
a more negative model of hypertension, than the patients in the second cluster. In the third
cluster there were significant differences from the other two in all the dimensions, except in
identity, which is lower than the other two models. There were no significant differences
concerning the demographic variables (gender, age, and education) according to each
illness schemata identified, from t-tests and Anova.
Illness schemata and choice of medication
In order to identify how these illness schemata stand in relation to the choice of medication
(generic versus brand), Pearson 2 tests were performed. The results indicated that patients
seem to differ in their choice of medication (generic or brand names) according to the three
Figure 1. Illness schemata of hypertensive patients (n¼ 191). r¼ reversed time (Means of the
dimensions of the Brief-IPQ).

































illness schemata that we identified (2(2)¼ 7.882; p5 0.019). The frequencies of illness
schemata by choice of medication are shown on Table 4. Preferences for a generic medicine
were 62% less than for a brand medicine (OR¼ 0.38; p¼ 0.01). The Odds ratio for
a individual in cluster 2 to adopt a generic medicine relative to a brand medicine as
compared to an individual with cluster 1 increased by 67% (OR¼ 1.67; p¼ 0.047). There
was an interaction between the illness schemata and the choice of generic vs. brand
medicine. Individuals in cluster 1 adopted 65% more brand medicines that what would be
expected if there were no interaction between the two variables (OR¼ 1.65; p¼ 0.005).
Patients with more serious illness schemata (first cluster) are more likely to choose a brand
medicine, whereas patients with a more positive perception of hypertension (second
cluster) were more likely to choose a generic medicine. The third group of patients (cluster
3 in Table 4) showed a ‘mixed model’ in that they were evenly divided between brand and
generic. In order to control for demographic factors, a analysis of covariance (Ancova)
in which illness perceptions were the dependent variables, choice of medication and type
of cluster were the independent variables, and sex (dummy variable), age, and level of
education as covariates, was conducted but this did not provide any statistical effect.
Discussion
The present study examined the illness perceptions of hypertensive patients and their
relationship with beliefs about specific medicines. Three distinct clusters of illness







Range M (SD) M (SD) M (SD) F Sig.
Consequences 0–10 8.09 (2.07)a 5.40 (2.84)b 3.95 (2.54)c 39.31 0.000***
Timeline 8.92 (1.93)a 8.99 (1.88)a 7.21 (2.67)b 11.28 0.000***
Personel control 2.70 (2.46)a 2.14 (1.77)a 5.47 (1.70)b 38.60 0.000***
Treatment control 1.52 (2.10)a 1.19 (1.34)a 4.26 (1.79)b 45.86 0.000***
Identity 7.33 (2.70)a 3.92 (2.84)b 3.12 (2.26)b 42.13 0.000***
Concern 9.12 (1.51)a 6.86 (2.57)b 5.49 (2.09)c 41.44 0.000***
Comprehensibility 3.00 (3.58)a 2.55 (2.10)a 6.30 (2.11)b 27.97 0.000***
Emotions 8.97 (1.55)a 4.14 (2.62)b 2.98 (3.00)c 104.86 0.000***
Note: a,b,cMeans sharing the same superscript are not significantly different according to the post hoc
Tukey  test.
***p5 0.001
Table 4. Frequencies of Illness schemata by choice of medication (N¼ 171).
Choice of medication Cluster 1 Cluster 2 Cluster 3 Total
Brand 41 (63.1%) 25 (38.5%) 21 (51.2%) 87 (50.9%)
Generic 24 (36.9%) 40 (61.5%) 20 (48.8%) 84 (49.1%)
Total 65 (100%) 65 (100%) 41 (100%) 171 (100%)

































schemata were found and these were related to the choice of treatment (generic versus
branded-medicine). Generic medicines were introduced in Portugal in 2000, but it was only
in 2004 that there was a significant increase in the number of units sold and in 2007
there was an increase of 26.5% in sales compared with that of 2006 (INFARMED, 2008).
These medicines can be prescribed by a doctor, or dispensed by a pharmacist if the doctor
allows the substitution of a branded medicine by a generic one, by ticking a box on the
prescription. Otherwise, for over-the-counter (OTC) medicines, the pharmacist can choose
what sort of medicine can be dispensed if the consumer does not have any preference.
The results of our study indicated that in general patients with hypertension seem to
have an overall illness schema which is similar to that found in previous studies (Ross
et al., 2004). The analysis also showed that their beliefs about the necessity of their
medicines outweighed their concerns. Horne (1999) suggested that necessity beliefs are
likely to be strong in patients with chronic illnesses. In the present study, patients’ illness
representations indicated that hypertension is seen as a long-term condition, which may be
essential for the continuation of medication taking, and explain the relatively strong belief
in the necessity of treatment. The beliefs about treatment were associated with the
dimensions of the illness perception since beliefs in personal and treatment control were
associated with beliefs about the necessity of treatment but not with concern. This result
suggests that patients holding beliefs that hypertension is amenable to control, were more
likely to believe in the necessity of treatment, and had lower concerns about their
medicines. Furthermore, it is possible that patients who keep their regular appointments
are more positively oriented for taking their medication. However, it seems that their
illness schemata were likely to influence their beliefs about medication concerning the
choice between generic and brand names. According to Horne and Weinman (1999),
beliefs about a particular illness may influence the choice of treatment, expectations for
recovery, and eventually adherence to treatment. The same authors argued that the beliefs
about an illness are interconnected with beliefs about medicines.
The hierarchical cluster analyses identified three distinct clusters of illness schemata,
which were different according to the choice of medication and independent of
demographic variables. Patients with a more negative model of hypertension (cluster 1)
showed serious perceptions of consequences, chronic timeline, a strong belief in personal
and treatment control, a strong identity, a very high illness concern, and a very negative
emotional representation, although they believed they had a good understanding of their
condition. Patients in the second cluster showed significant differences from those in
cluster 1 since their beliefs about consequences, identity, level of concern, and emotional
representations were less negative. In the third cluster there were significant differences
from the other two in all the dimensions, except in identity, which was lower than the other
two clusters. Thus these patients held more positive beliefs about the consequences of
hypertension, a more acute timeline, a weaker belief in personal and treatment control,
lower concern and comprehensibility, and a more positive emotional representation. These
results suggest that these illness perceptions are more consistent in predicting choice of
medication rather than demographic characteristics. However, this should be further
explored in a prospective study. According to Rao (2006), patients’ treatment choices will
depend on their beliefs about the perceived severity of their illness and on the perceived
effectiveness of treatment options. According to Inkster et al. (2006), medication
adherence in hypertensive patients may be influenced by patient’s knowledge, beliefs,
and attitudes about hypertension and its treatment. In the present study, patients with
a more serious model of hypertension were more likely to choose a branded-name
medicine, whereas patients with a more positive perception of hypertension in terms

































of consequences, personal and treatment control, and a more positive emotional
representation, were more likely to choose a generic medicine. Similar results have been
found in previous clinical studies, in which patients with chronic diseases showed a more
negative attitude towards generic drugs (Ganther & Kreling, 2000; Himmel et al., 2005).
Beliefs about treatment with generic drugs may be the result of the interaction between
information about these medicines and the perceived severity of the illness. These beliefs
and attitudes could have an impact on primary care because it might be more difficult for
doctors to persuade patients to accept generic prescriptions if they perceive their problems
as serious and less controllable. This may be particularly important for people who take
several medicines and may perceive any changes in their prescriptions as a potential threat
to their health. There is therefore a need to study how generic substitution is perceived by
patients in relation to potential side effects, efficacy, and confidence in their treatment.
Our results also indicated that the choice of treatment for the group of patients who have
a low identity score and a lower belief in personal and treatment control was split between
brand and generic. One possible explanation is that illness schemata may operate at
different cognitive levels in different patients, which may influence their perception of
treatment needed. According to Lahdenpera and Kyngas (2001) this cognitive variation
may influence the quality and quantity of care and support patients need. The same
authors noted that patients need to have knowledge about the therapeutic options for
hypertension, in order to adopt the treatment. Due to the fact that the use of generics in
Portugal is quite recent, patients may not be aware of the availability of generic medicines,
or may not have enough knowledge concerning the type of treatment they are taking.
Here, doctors are in an important position to inform patients about the equivalence in
efficacy of brand and generic drugs for hypertension. These health professionals play a key
role in influencing patients’ decision-making concerning branded or generic medicines
given the fact they may or may not allow the substitution of a brand by a generic medicine.
Ross et al. (2004) also argued that beliefs about medication are important for achieving
concordance between doctors and patients and may be a target for interventions to
improve adherence with the choice of treatment. These findings also raise questions about
the potential for mismatch between patients’ models of illness and those of health
professionals, which may be more important than medical factors in influencing the choice
of medication. Thus health professionals should explore patients’ beliefs about
hypertension and medicines as a basis for improving outcome. On the other hand, this
could serve as a basis for adjusting medication to patients’ own beliefs which could help to
get blood pressure under control.
Our study may have been limited by sample size, although we were able to detect
enough statistical power in order to reduce the probability of a type II error, controlling
for the nominal type I error. The level of education of the sample is low and the
completion of questionnaires may be a problem. One factor which limits the use
of questionnaires in older samples in Portugal is the relatively high rate of illiteracy
(INE, 2006). Some patients had problems filling in the questionnaires by themselves, and
required help from the research assistant. However, we believe that this sample may be
quite similar to a representative sample of Portuguese hypertensive patients, who are
compliant with their regular appointments and treatment. Given the fact that the majority
of patients were taking branded-name medicines, this limited the possibility of assessing
previous experience with generic medicines, which may have had some influence on the
results. Medicines are not the only treatment for hypertension and the management of the
disease is also done through lifestyle modification, weight loss, smoking cessation, and
diet modification (ESH & ESC, 2007). In the current study only beliefs about the illness

































and medication were assessed and it was not possible to assess other factors such as
co-morbidities which may influence the choice of medication.
The findings of the present study may contribute to increase our understanding of
the relationship between patients’ beliefs about hypertension and their beliefs concerning
treatment and preferences for medication when they are given a choice between generic
and brand medicines. Future research needs to further explore how and why patients form
specific beliefs concerning their hypertension, and which sort of illness beliefs can influence
treatment preferences in doctors and patients, since they may have implications for
adherence.
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